|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.280 USD | -1.31% |
|
0.00% | -43.35% |
| Market Cap | 32.67M 28.49M 26.38M 24.7M 46.32M 3.08B 46.6M 313M 121M 1.52B 123M 120M 5.27B | P/E 2026 * |
-0.76x | P/E 2027 * | -1.24x |
|---|---|---|---|---|---|
| Enterprise Value | 9.39M 8.19M 7.58M 7.1M 13.31M 886M 13.39M 89.96M 34.86M 436M 35.25M 34.49M 1.51B | EV / Sales 2026 * |
0.43x | EV / Sales 2027 * | -49.9x |
| Free-Float |
78.05% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Aligos Therapeutics, Inc.
| 1 day | -1.31% | ||
| Current month | -7.37% | ||
| 1 month | -1.49% | ||
| 3 months | -24.03% | ||
| 6 months | -49.08% | ||
| Current year | -43.35% |
| 1 week | 4.98 |  | 5.73 |
| 1 month | 4.8 | | 6.11 |
| Current year | 4.8 | | 10.49 |
| 1 year | 4.8 | | 13.69 |
| 3 years | 3.76 | | 46.8 |
| 5 years | 3.76 | | 709.75 |
| 10 years | 3.76 | | 937.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lawrence Blatt
CEO | Chief Executive Officer | 64 | 05/02/2018 |
Lesley Calhoun
DFI | Director of Finance/CFO | 60 | 01/06/2020 |
Julian Symons
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/05/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 01/08/2018 | |
K. Hirth
BRD | Director/Board Member | 74 | 01/08/2018 |
Lawrence Blatt
CHM | Chairman | 64 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-09 | Free | Chief Financial Officer | 37,485 | 0.7002% | ||
| 03-09 | Free | Chief Technology Officer | 23,310 | 0.4354% | ||
| 03-09 | Free | Controller/Auditor | 9,450 | 0.1765% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.31% | 0.00% | -36.92% | -80.80% | 32.67M | |
| +1.44% | +1.71% | -10.63% | -9.16% | 42.75B | |
| +0.37% | +9.22% | +308.19% | +562.02% | 34.65B | |
| +2.84% | +3.80% | +6.87% | +34.93% | 30.03B | |
| -1.70% | -7.34% | +8.51% | -22.34% | 28B | |
| -1.90% | +2.47% | +10.18% | +18.13% | 24.83B | |
| +1.22% | +7.06% | - | - | 14.34B | |
| +0.68% | -3.13% | +52.04% | +107.47% | 13.14B | |
| -0.57% | -2.43% | +5.18% | +4.20% | 12.61B | |
| -0.26% | +0.41% | +100.27% | +80.69% | 12.25B | |
| Average | +0.22% | +0.50% | +49.30% | +77.24% | 21.26B | |
| Weighted average by Cap. | +0.74% | +0.91% | +65.04% | +113.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.68M 18.9M 17.5M 16.39M 30.73M 2.05B 30.92M 208M 80.48M 1.01B 81.37M 79.62M 3.5B | 5M 4.36M 4.04M 3.78M 7.09M 472M 7.13M 47.9M 18.56M 232M 18.77M 18.37M 806M |
| Net income | -93.95M -81.92M -75.87M -71.02M -133M -8.87B -134M -900M -349M -4.36B -353M -345M -15.15B | -124M -108M -100M -93.9M -176M -11.72B -177M -1.19B -461M -5.77B -466M -456M -20.03B |
| Net Debt | -23.28M -20.3M -18.8M -17.6M -33.01M -2.2B -33.21M -223M -86.44M -1.08B -87.4M -85.52M -3.75B | -282M -246M -228M -213M -400M -26.62B -402M -2.7B -1.05B -13.1B -1.06B -1.04B -45.5B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 5.280 $ | -1.31% | 39,806 |
| 17/06/26 | 5.350 $ | +7.21% | 156,041 |
| 16/06/26 | 4.990 $ | -2.35% | 41,316 |
| 15/06/26 | 5.110 $ | -3.22% | 87,564 |
| 12/06/26 | 5.280 $ | 0.00% | 76,681 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALGS Stock
Select your edition
All financial news and data tailored to specific country editions
